Search Ontology:
ChEBI
alpha-L-Fucp-(1->2)-beta-D-Galp6S-(1->4)-beta-D-GlcpNAc
- Term ID
- CHEBI:85948
- Synonyms
-
- 6-deoxy-alpha-L-galactopyranosyl-(1->2)-6-O-sulfo-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- alpha-L-Fuc-(1->2)-beta-D-Gal6S-(1->4)-betaD-GlcNAc
- Fuca1-2(6S)Galb1-4GlcNAcb
- Fucalpha1-2(6S)Galbeta1-4GlcNAcbeta
- Fucalpha1-2[6OSO3]Galbeta1-4GlcbetaNAc
- L-fucopyranosyl-(1->2)-6-O-sulfo-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- L-fucosyl-(1->2)-6-O-sulfo-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine
- O-6-deoxy-alpha-L-galactopyranosyl-(1->2)-O-6-O-sulfo-beta-D-galactopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-beta-D-glucopyranose
- Definition
- alpha-L-Fucp-(1->2)-beta-D-Galp6S-(1->4)-D-GlcpNAc in which the anomeric configuration of the N-acetyl-D-glucosamine residue at the reducing end is beta.
- References
- Ontology
- ChEBI ( EBI )
- is a type of
-
Phenotype
Phenotype resulting from alpha-L-Fucp-(1->2)-beta-D-Galp6S-(1->4)-beta-D-GlcpNAc
Phenotype where environments contain alpha-L-Fucp-(1->2)-beta-D-Galp6S-(1->4)-beta-D-GlcpNAc
Phenotype modified by environments containing alpha-L-Fucp-(1->2)-beta-D-Galp6S-(1->4)-beta-D-GlcpNAc
Human Disease / Model Data